Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Maternal exposure to atrazine during lactation suppresses suckling- induced prolactin release and results in prostatitis in the adult offspring
1999
Apoptosis. Its significance in cancer and cancer Therapy
1994 Standout
Soy intake and cancer risk: A review of thein vitroandin vivodata
1994 Standout
Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat
2004
Diet and Its Preventive Role in Prostatic Disease
1999
Phyto-oestrogens and Western Diseases
1997 Standout
Mechanisms of Action and Clinical Uses of Estramustine
1990
Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers
2016
The biochemistry and medical significance of the flavonoids
2002 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Multi-targeted therapy of cancer by genistein
2008 Standout
Identification of rat prostatic steroid binding protein (PSBP) as an immunosuppressive factor
2001
Microtubules as a target for anticancer drugs
2004 Standout
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Identification of SecretaglobinScgb2a1as a target for developmental reprogramming by BPA in the rat prostate
2015
Active cell death in hormone-dependent tissues
1992
Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats
1992
Androgen‐supported estrogen‐enhanced epithelial proliferation in the prostates of intact noble rats
1989
Sex‐hormone‐induced inflammation and fibromuscular proliferation in the rat lateral prostate
1988
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.
1985 Nobel
Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate
2002
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Cellular response to androgen depletion and repletion in the rat ventral prostate: Autoradiography and morphometric analysis
1985
Phytoestrogens: epidemiology and a possible role in cancer protection.
1995 Standout
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
2015
THE INFLUENCE OF ENDOCRINE HORMONES ON THE AUTONOMIC NERVOUS SYSTEM
1981
Prostatic Acid Phosphatase: Its Current Clinical Status
1987
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
The effect of prolactin on human BPH epithelial cell proliferation
1985
Controls of Hair Follicle Cycling
2001 Standout
Organisation of collagen fibrils in tendon: changes induced by an anabolic steroid
1986
Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation
1984
The pathogenesis of benign prostatic hyperplasia
1980 Standout
Stromal-Epithelial Interactions in Sex Differentiation
1980
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Induction of the TRPM-2 gene in cells undergoing programmed death.
1989 Standout
Works of Jonas Müntzing being referenced
Hormonal control of zinc uptake and binding in the rat dorsolateral prostate.
1977
Effect of treatment on the expression of estramustine‐binding protein (EMBP) in prostatic cancer patients: An immunohistochemical study
1989
An immunohistochemical technique for localization and semiquantitation of estramustine‐binding protein (EMBP) in rat and human prostate
1989
Chalones and stroma as possible growth-limiting factors in the rat ventral prostate.
1979
Prostatitis in the Rat
1979
Histochemical and Biochemical Investigation of Advanced Prostatic Carcinoma Treated with Estramustine Phosphate, Estracyt
1973
Study on the Growth Limiting Mechanism in the Rat Ventral Prostate
1977
Histochemical and Biochemical Enzyme Studies in Prostatic Carcinomatous Tissue Before and During Treatment with Estrogen
1973
Chemotherapy principles in the treatment of prostatic cancer
1984
Effects of Sexual Hormones on the Adrenergic Innervation and the Monoamine Oxidase Activity in the Rat Ventral Prostate
1971
Treatment of prostatitis in the rat
1984
Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to Oestrogen
1979
Androgen and collagen as growth regulators of the rat ventral prostate
1980
Ultrastructure and immunohistochemistry of the lateral prostate in aged rats
1987
The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
1976